Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.alembicpharmaceuticals.com | |
Market Cap | 14,763.86 Cr. | |
Enterprise Value(EV) | 15,400.44 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 27.05 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 27.77 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.75 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 227.41 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 3.30 | Calculated using Price: 751.10 |
Dividend Yield | 1.07 | Period Ending 2023-03 |
No. of Shares Subscribed | 19.66 Cr. | 196,563,124 Shares |
FaceValue | 2 | |
About Alembic Pharmaceuticals Ltd. | ||
The company is principally engaged in the manufacturing and selling of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company presents an extensive range of branded and generic formulations, in compliance with international and national regulations, that cater to diverse therapeutic segments. |
1 Day |
|
+1.09% |
1 Week |
|
+4.15% |
1 Month |
|
+2.84% |
3 Month |
|
-2.10% |
6 Month |
|
+35.73% |
1 Year |
|
+26.72% |
2 Year |
|
-6.49% |
5 Year |
|
+22.26% |
10 Year |
|
+268.07% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 36.24 | 58.02 | 23.25 | 20.42 | 24.00 | 26.97 | 26.91 | 10.11 | 7.12 | |
Return on Capital Employed (%) | 37.54 | 65.86 | 28.87 | 22.15 | 22.66 | 23.30 | 26.28 | 11.25 | 7.44 | |
Return on Assets (%) | 18.76 | 33.75 | 14.97 | 12.25 | 13.15 | 14.64 | 17.22 | 7.34 | 5.15 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 885 | 1,597 | 1,902 | 2,220 | 2,719 | 3,219 | 5,067 | 5,238 | 4,370 | 4,470 | |
Non Curr. Liab. | 72 | 84 | 94 | 576 | 570 | 1,047 | 361 | 162 | 52 | 52 | |
Curr. Liab. | 684 | 944 | 814 | 1,267 | 1,664 | 1,752 | 1,533 | 1,831 | 1,641 | 1,810 | |
Minority Int. | 0 | 0 | -1 | -29 | |||||||
Equity & Liab. | 1,641 | 2,626 | 2,811 | 4,064 | 4,952 | 5,989 | 6,961 | 7,230 | 6,064 | 6,332 | |
Non Curr. Assets | 750 | 917 | 1,317 | 2,116 | 2,820 | 3,526 | 4,057 | 4,255 | 3,150 | 3,197 | |
Curr. Assets | 891 | 1,708 | 1,494 | 1,948 | 2,132 | 2,463 | 2,904 | 2,975 | 2,914 | 3,134 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,641 | 2,626 | 2,811 | 4,064 | 4,952 | 5,989 | 6,961 | 7,230 | 6,064 | 6,332 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 2,056 | 3,166 | 3,135 | 3,131 | 3,935 | 4,606 | 5,393 | 5,306 | 5,653 | 5,997 | |
Other Income | 12 | 9 | 3 | 35 | 27 | 14 | 87 | 50 | 3 | 23 | |
Total Income | 2,068 | 3,175 | 3,137 | 3,166 | 3,962 | 4,620 | 5,481 | 5,356 | 5,656 | 6,020 | |
Total Expenditure | -1,661 | -2,161 | -2,520 | -2,516 | -3,079 | -3,392 | -3,913 | -4,432 | -4,945 | -5,129 | |
PBIDT | 407 | 1,014 | 617 | 650 | 883 | 1,228 | 1,568 | 925 | 711 | 891 | |
Interest | -4 | -5 | -5 | -3 | -18 | -27 | -16 | -18 | -50 | -59 | |
Depreciation | -44 | -72 | -83 | -105 | -115 | -157 | -183 | -287 | -275 | -274 | |
Taxation | -76 | -216 | -122 | -120 | -157 | -199 | -253 | -104 | -13 | -3 | |
Exceptional Items | -44 | ||||||||||
PAT | 283 | 720 | 407 | 421 | 593 | 801 | 1,115 | 521 | 342 | 554 | |
Minority Interest | 0 | 0 | 1 | 28 | |||||||
Share Associate | 0 | -4 | -8 | -9 | 0 | 32 | -23 | ||||
Other Related Items | |||||||||||
Consolidated Net Profit | 283 | 720 | 403 | 413 | 584 | 829 | 1,147 | 521 | 342 | 532 | |
Adjusted EPS | 15 | 38 | 21 | 22 | 31 | 44 | 58 | 27 | 17 | 27 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 240 | 172 | 948 | 329 | 312 | 812 | 449 | 1,463 | 552 | 724 | |
Cash Fr. Inv. | -81 | -256 | -307 | -486 | -884 | -756 | -732 | -839 | -372 | -448 | |
Cash Fr. Finan. | -151 | 87 | -224 | -129 | 503 | 59 | 155 | -597 | -217 | -262 | |
Net Change | 8 | 3 | 417 | -286 | -69 | 115 | -128 | 27 | -37 | 14 | |
Cash & Cash Eqvt | 24 | 27 | 439 | 153 | 84 | 199 | 72 | 98 | 61 | 75 |
Wed, 29 Nov 2023
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DSP Trustee Pvt Ltd & Others |
Mon, 27 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached the intimation of loss of Share Certificates. |
Mon, 27 Nov 2023
Announcement under Regulation 30 (LODR)-Change in Management Appointment of SMP |
Fri, 01 Dec 2023 |
|
|
|
|
|